News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
661,813 Results
Type
Article (65745)
Company Profile (134)
Press Release (595934)
Multimedia
Podcasts (59)
Webinars (12)
Section
Business (179975)
Career Advice (2791)
Deals (32307)
Drug Delivery (100)
Drug Development (79420)
Employer Resources (162)
FDA (16624)
Job Trends (14377)
News (317095)
Policy (31626)
Tag
Academia (2891)
Academic (1)
Accelerated approval (6)
Adcomms (26)
Allergies (89)
Alliances (49770)
ALS (100)
Alzheimer's disease (1450)
Antibody-drug conjugate (ADC) (136)
Approvals (16600)
Artificial intelligence (276)
Autoimmune disease (24)
Automation (15)
Bankruptcy (339)
Best Places to Work (11135)
BIOSECURE Act (21)
Biosimilars (106)
Biotechnology (85)
Bladder cancer (76)
Brain cancer (30)
Breast cancer (296)
Cancer (2369)
Cardiovascular disease (183)
Career advice (2344)
Career pathing (34)
CAR-T (163)
Cell therapy (453)
Cervical cancer (20)
Clinical research (64234)
Collaboration (884)
Company closure (2)
Compensation (287)
Complete response letters (26)
COVID-19 (2676)
CRISPR (42)
C-suite (257)
Cystic fibrosis (108)
Data (2320)
Decentralized trials (2)
Denatured (22)
Depression (50)
Diabetes (266)
Diagnostics (6154)
Digital health (19)
Diversity (6)
Diversity, equity & inclusion (40)
Drug discovery (128)
Drug pricing (117)
Drug shortages (24)
Duchenne muscular dystrophy (101)
Earnings (66256)
Editorial (44)
Employer branding (23)
Employer resources (143)
Events (86909)
Executive appointments (759)
FDA (18027)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (790)
Gene editing (107)
Generative AI (26)
Gene therapy (334)
GLP-1 (731)
Government (4214)
Grass and pollen (5)
Guidances (160)
Healthcare (17895)
Huntington's disease (20)
IgA nephropathy (31)
Immunology and inflammation (127)
Indications (29)
Infectious disease (2829)
Inflammatory bowel disease (143)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (102)
Interviews (526)
IPO (14718)
IRA (39)
Job creations (3642)
Job search strategy (1952)
Kidney cancer (11)
Labor market (36)
Layoffs (456)
Leadership (23)
Legal (6994)
Liver cancer (78)
Lung cancer (330)
Lymphoma (155)
Machine learning (9)
Management (54)
Manufacturing (319)
MASH (76)
Medical device (12139)
Medtech (12142)
Mergers & acquisitions (18139)
Metabolic disorders (695)
Multiple sclerosis (89)
NASH (19)
Neurodegenerative disease (107)
Neuropsychiatric disorders (25)
Neuroscience (2035)
NextGen: Class of 2025 (6224)
Non-profit (4711)
Now hiring (28)
Obesity (358)
Opinion (251)
Ovarian cancer (81)
Pain (97)
Pancreatic cancer (87)
Parkinson's disease (160)
Partnered (24)
Patents (251)
Patient recruitment (119)
Peanut (48)
People (53935)
Pharmaceutical (40)
Pharmacy benefit managers (19)
Phase I (19893)
Phase II (28150)
Phase III (21178)
Pipeline (1381)
Policy (149)
Postmarket research (2674)
Preclinical (8994)
Press Release (67)
Prostate cancer (108)
Psychedelics (34)
Radiopharmaceuticals (243)
Rare diseases (405)
Real estate (5643)
Recruiting (67)
Regulatory (22620)
Reports (33)
Research institute (2629)
Resumes & cover letters (446)
Rett syndrome (6)
RNA editing (4)
RSV (45)
Schizophrenia (79)
Series A (129)
Series B (89)
Service/supplier (11)
Sickle cell disease (53)
Special edition (20)
Spinal muscular atrophy (160)
Sponsored (33)
Startups (3451)
State (2)
Stomach cancer (10)
Supply chain (65)
Tariffs (45)
The Weekly (36)
Vaccines (751)
Venture capitalists (38)
Weight loss (232)
Women's health (34)
Worklife (19)
Date
Today (107)
Last 7 days (924)
Last 30 days (3027)
Last 365 days (30672)
2025 (11330)
2024 (33157)
2023 (37553)
2022 (48310)
2021 (52432)
2020 (51173)
2019 (44647)
2018 (34034)
2017 (31714)
2016 (30975)
2015 (36113)
2014 (28846)
2013 (25572)
2012 (26436)
2011 (27097)
2010 (25878)
Location
Africa (927)
Alabama (57)
Alaska (6)
Arizona (173)
Arkansas (13)
Asia (40962)
Australia (7242)
California (5714)
Canada (1959)
China (541)
Colorado (260)
Connecticut (272)
Delaware (139)
Europe (92775)
Florida (888)
Georgia (198)
Idaho (53)
Illinois (532)
India (26)
Indiana (298)
Iowa (9)
Japan (172)
Kansas (98)
Kentucky (22)
Louisiana (12)
Maine (67)
Maryland (837)
Massachusetts (4224)
Michigan (214)
Minnesota (344)
Mississippi (2)
Missouri (83)
Montana (31)
Nebraska (24)
Nevada (66)
New Hampshire (60)
New Jersey (1720)
New Mexico (31)
New York (1735)
North Carolina (950)
North Dakota (8)
Northern California (2483)
Ohio (208)
Oklahoma (15)
Oregon (34)
Pennsylvania (1275)
Puerto Rico (14)
Rhode Island (28)
South America (1213)
South Carolina (27)
South Dakota (1)
Southern California (2196)
Tennessee (97)
Texas (895)
United States (21984)
Utah (177)
Virginia (151)
Washington D.C. (64)
Washington State (534)
West Virginia (2)
Wisconsin (53)
661,813 Results for "novartis institutes for biomedical research".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Manufacturing
Novartis Pledges $23B Boost to US Ops as Trump Intensifies Tariff Threats
Novartis plans to build seven new facilities in the U.S., touting the creation of up to 1,000 new jobs at the company. The new facilities will include a biomedical research hub in California, two radioligand plants, and four manufacturing sites.
April 11, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Clearside Biomedical Data Featured in Six Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting
May 12, 2025
·
8 min read
Spinal muscular atrophy
Novartis’ Intrathecal Zolgensma Effective in Older Children
After bringing Zolgensma to market in 2019 as the first gene therapy for spinal muscular atrophy, Novartis is back with an intrathecal formulation intended for older patients.
March 19, 2025
·
6 min read
·
Heather McKenzie
Rare diseases
Novartis’ Fabhalta Approved as First Therapy for Rare Kidney Disease
This is the third indication for Fabhalta after Novartis won FDA approval of the small molecule in paroxysmal nocturnal hemoglobinuria and primary immunoglobulin A nephropathy.
March 21, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Milken Institute SPARC Announces New Funding Programs, Reports, Collaborations to Advance Biomedical Research
November 14, 2024
·
5 min read
Press Releases
Clearside Biomedical Announces Six Abstracts Accepted for Presentation at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting
March 25, 2025
·
7 min read
Press Releases
Texas Biomedical Research Institute enters landmark partnership with Coalition for Epidemic Preparedness Innovations
October 29, 2024
·
3 min read
Patents
Novartis Scrambles to Squelch Copycats as Generics Gain Ground
Novartis is locked in a legal back-and-forth with MSN Pharma over alleged patent infringement of its heart failure drug Entresto.
January 17, 2025
·
2 min read
·
Tristan Manalac
Editorial
Biomedical Innovation in Jeopardy as Kennedy Distorts, Denies Scientific Truths
As the Trump administration—including HHS Secretary Robert F. Kennedy Jr.—plays fast and loose with scientific studies and facts, there may be a more sinister force at play: censorship.
May 2, 2025
·
6 min read
·
Heather McKenzie
Layoffs
Novartis Cuts MorphoSys Sites in Boston, Munich, Affecting 330 Jobs
The closures follow Novartis’s acquisition of MorphoSys earlier this year.
December 19, 2024
·
1 min read
·
Annalee Armstrong
1 of 66,182
Next
